71st AACC in Anaheim, August 2019

As in the year before, the Annual Scientific Meeting & Clinical Lab Expo in Anaheim was a great success for DiaSys Diagnostic Systems GmbH. We promoted our products to existing distributors as well as to potential prospects.

Thanks to lively visitor traffic at the DiaSys booth, the well established analytical systems respons®910 and SensoStar GLH six could be introduced even better to many visitors. The participation of our distributor in the U.S., Vidan Diagnostics, LLC, was a special highlight. Vidan signed an exclusive distribution agreement with DiaSys to market the following in the U.S.: the liquid-stable β-Hydroxybutyrate 21 FS, a ready-to-use reagent to measure beta-hydroxybuyrate, a marker used to improve the accuracy in diagnosing patients with diabetic ketoacidosis (DKA).

The knowledge and experience exchange with our partners in South and Central America was very promising for the future reagent and clinical chemistry device business.

DiaSys presented two scientific posters during AACC. The first one has been created in cooperation with Vidan Diagnostics and depicts evaluation data for our advanced β-Hydroxybutyrate 21 FS on Architect c8000TM clinical chemistry analyzer. Please pay attention to the poster, which is available on our website.

The second poster has been published by DiaSys India and shows the novel all-in-one disposable cartridge based electrolyte analyzer Qdx InstaLyte.